External validation of a non-invasive vaginal tool to assess the risk of intra-amniotic inflammation in pregnant women with preterm labor and intact membranes.

IF 1.7 4区 医学 Q3 OBSTETRICS & GYNECOLOGY
Teresa Cobo, Xavier P Burgos-Artizzu, Silvia Ferrero, Judith Balcells, Jordi Bosch, Amadeu Gené, Clara Murillo, Claudia Rueda, David Boada, Maria Teresa Sánchez-Antón, Marian Kacerovsky, Bo Jacobsson, Montse Palacio
{"title":"External validation of a non-invasive vaginal tool to assess the risk of intra-amniotic inflammation in pregnant women with preterm labor and intact membranes.","authors":"Teresa Cobo, Xavier P Burgos-Artizzu, Silvia Ferrero, Judith Balcells, Jordi Bosch, Amadeu Gené, Clara Murillo, Claudia Rueda, David Boada, Maria Teresa Sánchez-Antón, Marian Kacerovsky, Bo Jacobsson, Montse Palacio","doi":"10.1515/jpm-2024-0178","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To prospectively validate the diagnostic performance of a non-invasive point-of-care tool (Rapid IAI System), including vaginal alpha-fetoprotein and interleukin-6, to predict the occurrence of intra-amniotic inflammation in a Spanish cohort of patients admitted with a diagnosis of preterm labor and intact membranes.</p><p><strong>Methods: </strong>From 2017 to 2022, we prospectively evaluated a cohort of pregnant women diagnosed with preterm labor and intact membranes admitted below 34+0 weeks who underwent amniocentesis to rule-in/out intra-amniotic infection and/or inflammation. Vaginal sampling was performed at the time of amniocentesis or within 24-48 h. Amniotic fluid IL-6, vaginal alpha-fetoprotein and vaginal IL-6 concentrations were measured using a point-of-care tool provided by Hologic Inc., \"Rapid IAI System\". We defined intra-amniotic inflammation when amniotic fluid IL-6 values were greater than 11.3 ng/mL. During recruitment, clinicians were blinded to the results of the point-of-care tool. The original prediction model proposed by Hologic Inc. to predict intra-amniotic inflammation was validated in this cohort of patients.</p><p><strong>Results: </strong>We included 151 patients diagnosed with preterm labor and intact membranes. Among these, 29 (19.2 %) had intra-amniotic inflammation. The algorithm including vaginal IL-6 and alpha-fetoprotein showed an area under curve to predict intra-amniotic inflammation of 80.3 % (±5.3 %) with a sensitivity of 72.4 %, specificity of 84.6 %, positive predictive valuve (PPV) of 52.5 %, negative predictive value (NPV) of 92.9 %, and a positive likelihood ratio (LR+) of 4.6 and negative likelihood ratio (LR-) of 0.33.</p><p><strong>Conclusions: </strong>External validation of a non-invasive rapid point-of-care tool, including vaginal alpha-fetoprotein and IL-6, showed very good diagnostic performance for predicting the absence of intra-amniotic inflammation in women with preterm labor and intact membranes.</p>","PeriodicalId":16704,"journal":{"name":"Journal of Perinatal Medicine","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Perinatal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1515/jpm-2024-0178","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To prospectively validate the diagnostic performance of a non-invasive point-of-care tool (Rapid IAI System), including vaginal alpha-fetoprotein and interleukin-6, to predict the occurrence of intra-amniotic inflammation in a Spanish cohort of patients admitted with a diagnosis of preterm labor and intact membranes.

Methods: From 2017 to 2022, we prospectively evaluated a cohort of pregnant women diagnosed with preterm labor and intact membranes admitted below 34+0 weeks who underwent amniocentesis to rule-in/out intra-amniotic infection and/or inflammation. Vaginal sampling was performed at the time of amniocentesis or within 24-48 h. Amniotic fluid IL-6, vaginal alpha-fetoprotein and vaginal IL-6 concentrations were measured using a point-of-care tool provided by Hologic Inc., "Rapid IAI System". We defined intra-amniotic inflammation when amniotic fluid IL-6 values were greater than 11.3 ng/mL. During recruitment, clinicians were blinded to the results of the point-of-care tool. The original prediction model proposed by Hologic Inc. to predict intra-amniotic inflammation was validated in this cohort of patients.

Results: We included 151 patients diagnosed with preterm labor and intact membranes. Among these, 29 (19.2 %) had intra-amniotic inflammation. The algorithm including vaginal IL-6 and alpha-fetoprotein showed an area under curve to predict intra-amniotic inflammation of 80.3 % (±5.3 %) with a sensitivity of 72.4 %, specificity of 84.6 %, positive predictive valuve (PPV) of 52.5 %, negative predictive value (NPV) of 92.9 %, and a positive likelihood ratio (LR+) of 4.6 and negative likelihood ratio (LR-) of 0.33.

Conclusions: External validation of a non-invasive rapid point-of-care tool, including vaginal alpha-fetoprotein and IL-6, showed very good diagnostic performance for predicting the absence of intra-amniotic inflammation in women with preterm labor and intact membranes.

评估早产和胎膜未破孕妇羊膜腔内炎症风险的无创阴道工具的外部验证。
目的前瞻性验证一种无创性护理点工具(快速羊膜腔穿刺系统)的诊断性能,包括阴道甲胎蛋白和白细胞介素-6,以预测西班牙队列中诊断为早产和胎膜未破患者羊膜腔内炎症的发生:从2017年到2022年,我们对一组被诊断为早产和胎膜未破的孕妇进行了前瞻性评估,这些孕妇在34+0周以下入院,接受了羊膜穿刺术以排除羊膜腔内感染和/或炎症。阴道采样在羊膜腔穿刺时或 24-48 小时内进行。羊水IL-6、阴道甲胎蛋白和阴道IL-6的浓度是通过Hologic公司提供的护理点工具 "Rapid IAI System "进行测量的。当羊水IL-6值大于11.3纳克/毫升时,我们将其定义为羊膜腔内炎症。在招募过程中,临床医生对护理点工具的结果是盲法。Hologic 公司提出的预测羊膜腔内炎症的原始预测模型在这组患者中得到了验证:我们共纳入了 151 名被诊断为早产且胎膜未破的患者。其中,29 例(19.2%)有羊膜腔内炎症。包括阴道 IL-6 和甲胎蛋白在内的算法预测羊膜腔内炎症的曲线下面积为 80.3 % (±5.3 %),灵敏度为 72.4 %,特异性为 84.6 %,阳性预测值 (PPV) 为 52.5 %,阴性预测值 (NPV) 为 92.9 %,阳性似然比 (LR+) 为 4.6,阴性似然比 (LR-) 为 0.33:无创快速护理点工具(包括阴道甲胎蛋白和 IL-6)的外部验证表明,该工具在预测早产和胎膜未破产妇羊膜腔内无炎症方面具有非常好的诊断性能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Perinatal Medicine
Journal of Perinatal Medicine 医学-妇产科学
CiteScore
4.40
自引率
8.30%
发文量
183
审稿时长
4-8 weeks
期刊介绍: The Journal of Perinatal Medicine (JPM) is a truly international forum covering the entire field of perinatal medicine. It is an essential news source for all those obstetricians, neonatologists, perinatologists and allied health professionals who wish to keep abreast of progress in perinatal and related research. Ahead-of-print publishing ensures fastest possible knowledge transfer. The Journal provides statements on themes of topical interest as well as information and different views on controversial topics. It also informs about the academic, organisational and political aims and objectives of the World Association of Perinatal Medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信